Otwarty dostęp

Liposomal-lipopolysaccharide vaccine extracted from Proteus mirabilis induces moderate TLR4 and CD14 production


Zacytuj

1. Hegazy WAH. Diclofenac inhibits virulence of Proteus mirabilis isolated from diabetic foot ulcer. Afr J Microbiol. Res. 2016;10:733-43.10.5897/AJMR2016.8043Search in Google Scholar

2. Schaffer JN, Pearson MM. Proteus mirabilis and urinary tract infections. J Microbiol Spect. 2015;3(5).10.1128/microbiolspec.UTI-0017-2013463816326542036Search in Google Scholar

3. Brzozowska E, Pyra A, Pawlik K, Janik M, Górska S., Urbańska N. Hydrolytic activity determination of tail tubular Protein A of Klebsiella pneumoniae bacteriophages towards saccharide substrates. J Sci Rep. 2017;7(1):18048.10.1038/s41598-017-18096-1574170929273737Search in Google Scholar

4. Brotzki CR, Mergenhagen KA,, Bulman ZP, Tsuji BT, Berenson ChS. Native valve Proteus mirabilis endocarditis: successful treatment of a rare entity formulated by in vitro synergy antibiotic testing. BMJ Case Rep. 2016;bcr2016215956.10.1136/bcr-2016-215956507370227797858Search in Google Scholar

5. Wang Y, Zhang S, Yu J, Zhang H, Yuan Z, Sun Y, Song H. An outbreak of Proteus mirabilis food poisoning associated with eating stewed pork balls in brown sauce, Beijing. J Food Control. 2010; 21(3):302-5.10.1016/j.foodcont.2009.06.009Search in Google Scholar

6. Cohen-Nahum K, Saidel-Odes L, Riesenberg K, Schlaeffer F, Borer A. Urinary tract infections caused by multi-drug resistant Proteus mirabilis: risk factors and clinical outcomes. J Infection. 2010;38(1): 41-6.10.1007/s15010-009-8460-519998053Search in Google Scholar

7. NakanoR, Nakano A, Abe M, Inoue M, Okamoto R. Regional outbreak of CTX-M-2 β-lactamase-producing Proteus mirabilis in Japan. J Med Microbiol. 2012;61(12):1727-35.10.1099/jmm.0.049726-022935848Search in Google Scholar

8. Nagano N, Shibata N, Saitou Y, Nagano Y, Arakawa Y. Nosocomial outbreak of infections by Proteus mirabilis that produce Extended – spectrum CTX-M-2 type β-lactamase. J Clin Microbiol. 2003;41(12): 5530-6.10.1128/JCM.41.12.5530-5536.200330898514662935Search in Google Scholar

9. Jain S, Gaind R, Kothari C, Sehgal R, Shamweel A, Thukral SS, et al. VEB-1 extended-spectrum β-lactamase-producing multidrug-resistant Proteus mirabilis sepsis outbreak in a neonatal intensive care unit in India: clinical and diagnostic implications. JMM Case Rep. 2016;3(4): e005056. doi: 10.1099/jmmcr.0.005056.10.1099/jmmcr.0.005056533024628348778Open DOISearch in Google Scholar

10. Rogan D, Babiuk LA. Novel vaccines from biotechnology. J Rev Sci Tech. 2005;24(1):159-74.10.20506/rst.24.1.1561Search in Google Scholar

11. Kim D, Heajun JH, Lim L, Kyung MW, Hyun MR, Shik G, et al. N-acetyl cysteine Prevents LPS induced pro-inflammatory cytokines and MMP2 Production in Gingival fibroblast. Arch Pharm Res. 2007; 30(10):1283-92.10.1007/BF02980269Search in Google Scholar

12. Darweesh MF. Molecular characterization of ESBL gene in Citrobacter spp. and antibacterial activity of omega-3 against resistant isolates. Curr Issues Phar Med Sci. 2017;30(3):156-61.10.1515/cipms-2017-0029Search in Google Scholar

13. Christensen D, Korsholm KS, Andersen P, Agger EM. Cationic liposomes as vaccine adjuvants. J Expert Review Vacc. 2011;10(4): 513-21.10.1586/erv.11.17Search in Google Scholar

14. Alavi M, Karimi N, Safaei M. Application of various types of liposomes in drug delivery systems. J Adv Pharm Bull. 2017;7(1):3.10.15171/apb.2017.002Search in Google Scholar

15. Naser HH, Salih SM, Al-Shaibani AB. Protective humoral immunity induced by lipopolysaccharide incorporated liposome in mice against shigellaflexneri infection. J Al-Nahrain Univ. 2013; 16(3):205-13.10.22401/JNUS.16.3.29Search in Google Scholar

16. Miernikiewicz P, Kłopot A, Soluch R, Szkuta P, Kęska W, Hodyra-Stefaniak K, et al. T4 phage tail adhesin gp12 counteracts LPS-induced inflammation in vivo. J. Frontiers Microbiol. 2016;7:1112.10.3389/fmicb.2016.01112Search in Google Scholar

17. Dharmadhikari SM, Peshwe AS. Molecular level studies on multiple antibiotic and serum resistance in UTI pathogens. Indian J Biotechnol. 2009;8:40-5.Search in Google Scholar

18. Silipo A, Lanzetta R, Amoresano A, Parrilli M, Moliaro A. Ammonium hydroxide hydrolysis: a valuable support in the MALDITOF mass spectrometry analysis of lipid A fatty acid distribution. J Lipid Res. 2002;43:2188-95.10.1194/jlr.D200021-JLR200Search in Google Scholar

19. Chandan V, Fraser AD. Simple extraction of Campylobacter lipopolysaccharide and protein antigens and production of their antibodie in egg yolk. Inter L Food Microbiol. 1994;22:189-200.10.1016/0168-1605(94)90141-4Search in Google Scholar

20. Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. Determination of sugars and related substances. J Anal Chem. 1956;28: 350-3562110.1021/ac60111a017Search in Google Scholar

21. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Ann Biochem. 1976;72:248-254.10.1016/0003-2697(76)90527-3Search in Google Scholar

22. Xianguo H, Ursula M. Antifungal compound from Solanum nigrescens. J Ethanopharm. 1994;43:173-7.10.1016/0378-8741(94)90039-6Search in Google Scholar

23. Reed LJ, Muench HA. simple method of estimation fifty percent end points. Am J Hyg. 1938;27:493-8.10.1093/oxfordjournals.aje.a118408Search in Google Scholar

24. Alui Y, Nwude N. Determination of the medin lethal dose (LD 50) In: Velerenary Pharmacology and Toxicology Experiments. J. Baraka Press Zaria; 1982:104-22.Search in Google Scholar

25. Rittig MG, Kaufmann A, Robins A, Shaw B, Sprenger H, Gemsa D, et al. Smooth and rough lipopolysaccharide phenotypes of Brucella induce different intracellular trafficking and cytokine/chemokine release in human monocytes. J Leuk Biol. 2003;74(6):1045-55.10.1189/jlb.0103015Search in Google Scholar

26. Malik SN. Study the effect of polysaccharide extracted from Proteus merabilis in protect UTI in animal lab. Master thesis - Baghdad Uni. College of science. (In Arabic) 2006.Search in Google Scholar

27. Lan F, Yue X, Ren G, Wang Y, Xia T. Serum toll-like receptors are potential biomarkers of radiation pneumonia in locally advanced NSCLC. Inter J Clin Exper Path. 2014;7(11):8087.Search in Google Scholar

28. Ghosh C, Bishayi B. Characterization of toll-like receptor-4 (TLR-4) in the spleen and thymus of Swiss Albino mice and its modulation in experimental endotoxemia. J Immunol Res. 2015.10.1155/2015/137981Search in Google Scholar

29. MacRae S, Herman C, Stulting RD, Lippman R, Whipple D, Cohen E, Phillips D. Corneal ulcer and adverse reaction rates in premarket contact lens studies. AmJ Ophthal. 1991;111(4):457-465.10.1016/S0002-9394(14)72381-5Search in Google Scholar

30. Watanabe S, Kumazawa Y, Inoue J. Liposomal lipopolysaccharide initiates TRIF-dependent signaling pathway independent of CD14. PLoS One. 2013;8(4), e60078.10.1371/journal.pone.0060078Search in Google Scholar

31. Heldwein KA, Fenton MJ. The role of Toll-like receptors in immunity against mycobacterial infection. Microb Infect. 2002;4(9):937-44.10.1016/S1286-4579(02)01611-8Search in Google Scholar

32. Stils Jr, Harold F. Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants. J. ILAR46. 2005;3:280-293.10.1093/ilar.46.3.280Search in Google Scholar

33. Karananou P, Fleva A, Tramma D, Alataki A, Pavlitou-Tsiontsi A, Emporiadou-Peticopoulou M, Papadopoulou-Alataki E. Altered expression of TLR2 and TLR4 on peripheral CD14+ blood monocytes in children with urinary tract infection. BioMed Res Inter. 2016.10.1155/2016/6052891487198127252945Search in Google Scholar

34. Landmann R, Knopf HP, Link S, Sansano S, Schumann R, Zimmerli W. Human monocyte CD14 is upregulated by lipopolysaccharide. J Infect Immun. 1996;64(5):1762-9.10.1128/iai.64.5.1762-1769.19961739908613389Search in Google Scholar

35. Stewart EC, McIntosh TJ, Poxton, IR.The biological activity of a liposomal complete core lipopolysaccharide vaccine. J Endotoxin Res. 2002;8(1):39-46.10.1177/09680519020080010401Search in Google Scholar

36. O’Hagan TD, Friedland LR, Hanon E, Didierlaurent AM. Towards an evidence based approach for the development of adjuvanted vaccines. Curr Opin Immunol. 2017;47:93-102.10.1016/j.coi.2017.07.01028755542Search in Google Scholar

37. Abid AJ, Alwan SJ. Role of T regulatory cells with valvular heart disease. Res J Pharm Biol Chem Sci. 2016;7(3):1473-8.Search in Google Scholar

38. Khadhim MM, Al-Hajjiah NN, Shaheed OM. Detection of the CD64 on neutrophils and CD69 on lymphocytes by flowcytometry as a marker for early diagnosis of neonatal sepsis. Sepsis, 2015;8:9.Search in Google Scholar

eISSN:
2300-6676
ISSN:
2084-980X
Język:
Angielski
Częstotliwość wydawania:
4 razy w roku
Dziedziny czasopisma:
Medicine, Clinical Medicine, other, Pharmacology, Toxicology, Pharmacy